Evidence map›Paper›PMID 37656169›Full record

ArticleeLife2023

Examining the association of clinician characteristics with perceived changes in cervical cancer screening and colposcopy practice during the COVID-19 pandemic: a mixed methods assessment.

Lindsay Fuzzell, Naomi C Brownstein, Holly B Fontenot, Paige W Lake, Alexandra Michel, Ashley Whitmer, Sarah L Rossi, McKenzie McIntyre, Susan T Vadaparampil, Rebecca B Perkins

Open access · goldAbstract read
In one paragraph

Article in eLife, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Lindsay FuzzellH. Lee Moffitt Cancer Center & Research Institute, Health Outcomes and Behavior, Tampa, United States.ORCID 0000-0001-9688-5365
Naomi C BrownsteinMedical University of South Carolina, Charleston, United States.
Holly B FontenotUniversity of Hawaii at Manoa, Nancy Atmospera-Walch School of Nursing, Honolulu, United States.
Paige W LakeH. Lee Moffitt Cancer Center & Research Institute, Health Outcomes and Behavior, Tampa, United States.ORCID 0000-0002-5591-6417
Alexandra MichelUniversity of Hawaii at Manoa, Nancy Atmospera-Walch School of Nursing, Honolulu, United States.
Ashley WhitmerH. Lee Moffitt Cancer Center & Research Institute, Health Outcomes and Behavior, Tampa, United States.
Sarah L RossiBoston University, Chobanian & Avedisian School of Medicine, Boston, United States.
McKenzie McIntyreH. Lee Moffitt Cancer Center & Research Institute, Health Outcomes and Behavior, Tampa, United States.
Susan T VadaparampilH. Lee Moffitt Cancer Center & Research Institute, Health Outcomes and Behavior, Tampa, United States.
Rebecca B PerkinsBoston University, Chobanian & Avedisian School of Medicine, Boston, United States.
Moffitt Cancer Center · USBoston University · USUniversity of Hawaiʻi at Mānoa · USMedical University of South Carolina · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The COVID-19 pandemic led to reductions in cervical cancer screening and colposcopy. Therefore, in this mixed method study we explored perceived pandemic-related practice changes to cervical cancer screenings and colposcopies. Methods: In 2021, a national sample of 1251 clinicians completed surveys, including 675 clinicians who performed colposcopy; a subset (n=55) of clinicians completed qualitative interviews. Results: Nearly half of all clinicians reported they were currently performing fewer cervical cancer screenings (47%) and colposcopies (44% of those who perform the procedure) than before the pandemic. About one-fifth (18.6%) of colposcopists reported performing fewer LEEPs than prior to the pandemic. Binomial regression analyses indicated that older, as well as internal medicine and family medicine clinicians (compared to OB-GYNs), and those practicing in community health centers (compared to private practice) had higher odds of reporting reduced screening. Among colposcopists, internal medicine physicians and those practicing in community health centers had higher odds of reporting reduced colposcopies. Qualitative interviews highlighted pandemic-related care disruptions and lack of tracking systems to identify overdue screenings. Conclusions: Reductions in cervical cancer screening and colposcopy among nearly half of clinicians more than 1 year into the pandemic raise concerns that inadequate screening and follow-up will lead to future increases in preventable cancers. Funding: This study was funded by the American Cancer Society, who had no role in the study's design, conduct, or reporting.

Indexed as

COVID-19Uterine Cervical NeoplasmsColposcopyEarly Detection of CancerFemaleHumansPandemicsPregnancyUnited Statescervical cancer preventioncervical cancer screeningepidemiologyglobal healthHPVnone

Identifiers

PMID37656169
PMCPMC10473834
OpenAlexW4386348006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.